Cerevel Therapeutics ( NASDAQ:CERE – Get Free Report ) issued its earnings results on Wednesday. The biotechnology company reported ($0.63) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.65) by $0.02, Briefing.com reports. During the same quarter in the previous year, the firm earned ($0.61) earnings per share. Cerevel Therapeutics Trading Down 9.9 % CERE stock traded down $2.61 during midday trading on Thursday, hitting $23.72. The stock had a trading volume of 1,456,124 shares, compared to its average volume of 579,952.

https://www.dailypolitical.com/2023/08/03/cerevel-therapeutics-nasdaqcere-issues-earnings-results.html

#dailypolitical